Healthcare

Neurovascular Devices Market worth $7.22 billion in 2030 with 9.3% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 6, 2025, 10:30 GMT-05

MARKETSANDMARKETS

Read full article →

Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care

CASTELVECCHIO PASCOLI, Italy, Nov. 6, 2025, 08:38 GMT-05

KEDRION-IPIC-2025

Read full article →

SkylineDx Wins 2025 BioTech Breakthrough Award for "Diagnostics Company of the Year"

ROTTERDAM, Netherlands and SAN DIEGO, Nov. 6, 2025, 07:00 GMT-05

SkylineDx

Read full article →

Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30

HANGZHOU, China, Nov. 6, 2025, 05:18 GMT-05

Tigermed-Top-30

Read full article →

138th Canton Fair: Rising Demand for At-Home Healthcare Spurs Innovation in Smart Rehab and Wellness Tech

GUANGZHOU, China, Nov. 6, 2025, 00:26 GMT-05

CantonFair-Awareness

Read full article →

The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

SHANGHAI, Nov. 6, 2025, 19:42 GMT-05

CorrectSequenceTherap

Read full article →

Rheumatoid Arthritis Market to Surge by 2034 as Next-Generation Biologics and JAK Inhibitors Gain Traction | DelveInsight

LAS VEGAS, Nov. 5, 2025, 17:31 GMT-05

DELVEINGISHT-HEALTH

Read full article →

Hyaluronic Acid Products Market to Reach $20 billion, Globally, by 2034 at 7.7% CAGR: Allied Market Research

WILMINGTON, Del., Nov. 5, 2025, 10:31 GMT-05

ALLIEDMARKETRESEARCH

Read full article →

Ophthalmic Equipment Market worth US$26.14 billion by 2030 with 5.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 5, 2025, 10:30 GMT-05

MarketsandMarkets

Read full article →

Santen Receives UK Approval for Ryjunea® (low-dose atropine 0.1 mg/ml) to Slow Progression of Childhood Myopia

LONDON and OSAKA, Japan, Nov. 5, 2025, 09:04 GMT-05

SANTEN-MHRA-APPROVAL

Read full article →

Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors

PLAINSBORO, N.J. and BAGSVÆRD, Denmark, Nov. 5, 2025, 08:15 GMT-05

Novo-Nordisk-Wegovy

Read full article →

NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance

NAPLES, Fla. and STAMFORD, Conn., Nov. 5, 2025, 07:00 GMT-05

CARISTO-NCH

Read full article →

BizClik Launches Global Webinar Series Uniting Global Leaders Across Key Industries - Live November 2025

LONDON, Nov. 5, 2025, 09:51 GMT-05

BIZCLIK-new-webinars

Read full article →

Companion Diagnostics Market Worth USD 15.6 Bn by 2030 Growing at 12.4% CAGR, says Mordor Intelligence

HYDERABAD, India, Nov. 5, 2025, 05:01 GMT-05

MORDOR-INTELLIGENCE

Read full article →

Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential

STOCKHOLM, Nov. 5, 2025, 03:01 GMT-05

MOBERG-PHARMA-Karo-He

Read full article →

Top-rated Canadian healthcare provider adopts Sectra's enterprise imaging as a cloud solution for enhanced patient care

LINKÖPING, Sweden and MISSISSAUGA, ON, Nov. 5, 2025, 02:52 GMT-05

Sectra

Read full article →

Karo Healthcare enters an exclusive license agreement with Moberg Pharma for MOB-015 in Europe

STOCKHOLM, Nov. 5, 2025, 02:49 GMT-05

KARO-Agreement

Read full article →

Tinnitus UK Rates Lenire as Most Effective Treatment Option

DUBLIN, Nov. 5, 2025, 00:30 GMT-05

Neuromod-Devices

Read full article →

Cholestatic Pruritus Market is Predicted to Exhibit Remarkable Growth at a CAGR of 23.4% in the US During the Forecast Period (2025-2034) | DelveInsight

LAS VEGAS, Nov. 4, 2025, 17:31 GMT-05

DELVEINSIGHT

Read full article →

Point-of-Care Molecular Diagnostics Market Surges to USD 15.2 Billion by 2033, Propelled by 10.2% CAGR - Verified Market Reports®

LEWES, Del., Nov. 4, 2025, 10:50 GMT-05

VERIFIEDMARKETREPORTS

Read full article →